Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    21041705 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: Alemtuzumab (Campath)

Study has passed its completion date and status has not been verified in more than two years.